Anzeige
Mehr »
Sonntag, 15.02.2026 - Börsentäglich über 12.000 News
20 Mio. € Bewertung. Zwei zugelassene Psychedelika-Produkte. NASDAQ-Uplist in Arbeit.
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
198 Leser
Artikel bewerten:
(1)

Innovista Health Appoints Managed Care Leader Jigar Desai as New CEO

OAK BROOK, IL / ACCESSWIRE / September 16, 2024 / Innovista Health welcomes Jigar Desai as its new President and Chief Executive Officer. Desai will lead the managed services organization as it further positions itself as the partner of choice to payers and independent physician groups in the design, management and administration of value-based care arrangements.

Innovista Health

Innovista Health



Desai brings more than 20 years of managed care experience to Innovista Health. Previously, he held senior leadership roles at several Medicare-focused managed care organizations. Most recently, he served as executive chairman of a private equity-backed Medicare platform, where he implemented turnaround plans and led the acquisition of a large managed care company.

Prior to that role, Jigar served as CFO and then CEO at America's 1st Choice group of companies (AFC) at Elevance Health. Under his leadership, AFC served more 130,000 Medicare Advantage lives and ranked as the second largest chronic condition special needs plans in the U.S. Jigar also previously held finance positions at WellCare and Universal Health.

As President and CEO of Innovista Health, Desai will lead its three divisions:

Value-based Care: Comprehensive enablement programs-including multi-payer program administration, value-based clinical services expertise, and operational support-to drive practice transformation.

Delegated Operations: Management of administrative activities such as claims processing, customer service, and utilization management to help providers deliver high-quality care with minimal burden.

Care Delivery: Operation of 10 clinics in Texas that offer primary care services, in-house labs and diagnostic imaging, and referral and care coordination. Innovista Medical Center represents a new organizational commitment for continued innovation in value-based care by providing high-quality, affordable primary care in Dallas and Houston, two of the nation's top 10 most populous metro areas.

Innovista Health is a subsidiary of Health Care Service Corporation, which serves the health care needs of over 23 million people nationwide.

"I am excited to lead Innovista Health into its next chapter of growth and innovation. By leveraging our expertise, team, and technology, we can empower providers to deliver high-quality, cost-effective care that truly puts patients first," Desai said. "I look forward to working with our dedicated staff and partners to advance this mission and make a lasting impact on the communities we serve."

###

About Innovista Health
Innovista Health is a value-based enablement and management services organization, with a suite of services that promote clinical excellence, deep analytics, and incentive alignment that enhances the quality of patient care while decreasing healthcare costs via operational excellence. Innovista also delivers primary care under the Innovista Medical Center brand and supports independent providers and payer partners in value-based savings and shared-risk models. Innovista Health is a wholly owned subsidiary of Health Care Service Corporation.

Media Contact: Dana Guilfoyle | dguilfoyle@innovista-health.com

Contact Information
Dana Guilfoyle
dguilfoyle@innovista-health.com

Related Images

Innovista Health

Innovista Health

Jigar Desai, President and CEO, Innovista Health

Jigar Desai, President and CEO, Innovista Health

SOURCE: Innovista Health

.

View the original press release on newswire.com.

© 2024 ACCESS Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.